1.Anti-tumor Drug Delivery and Tumor Therapy Based on Metal-organic Frameworks
Bingtai LI ; Bangguo KOU ; Yongjie JIANG ; Pan BIAN ; Lanning YIN
Cancer Research on Prevention and Treatment 2022;49(8):832-837
Metal-organic frameworks (MOFs) are mixed porous materials which are composed of metal clusters or ions and organic pillars. Given their channel tunability, high porosity, large specific surface area, and good biocompatibility, MOFs can be combined with various biological macromolecules. In recent years, they have been widely studied in the field of biomedicine, especially in the loading of anti-tumor drugs, showing great application prospects. Multifunctional anti-tumor MOF combined with different therapeutic methods provides a new idea and method for tumor treatment. On the basis of the structure of MOF, this paper introduces the advantages of using MOF to load anti-tumor drugs and reviews the application of MOF in tumor therapy.
2.Research progress on the expression of CPNE in malignant tumor and its effect on invasion and metastasis
Bangguo KOU ; Yongjie JIANG ; Pan BIAN ; Bingtai LI ; Lanning YIN
International Journal of Surgery 2021;48(11):788-792
Malignant tumor has become one of the main reasons threatening human health. Invasion and metastasis are the important biological characteristics of malignant tumor and the main cause of death of malignant tumor patients. CPNE is highly expressed in malignant tumors, and its family may interact with proteins and MicroRNA to participate in MAPK, PI3K/AKT and other signal pathways to mediate tumor cell proliferation, invasion and metastasis. This article reviews the expression of CPNE in malignant tumors and its effect on invasion and metastasis.
3.Expression of PLEK2 in malignant tumors and its influence on invasion and metastasis
Yongjie JIANG ; Bangguo KOU ; Pan BIAN ; Bingtai LI ; Lanning YIN
International Journal of Surgery 2022;49(2):122-127
PLEK2 (Pleckstrin-2) is a subtype of platelets and leukocytes Pleckstrin, located at 14q23.3-q24.1. Its encoded protein contains 353 amino acids. It plays a role in a variety of cells other than immune cells. The research is relatively limited, mainly involved in the reorganization of cytoskeleton proteins and the regulation of cell extension and migration. PLEK2 plays an important role in the occurrence, development and metastasis of a variety of tumors, and can participate in the regulation of a variety of signal pathways, thereby regulating tumor cell proliferation, invasion and metastasis. PLEK2 is up-regulated in a variety of tumors and has carcinogenic properties. This article reviews the regulatory role of PLEK2 in tumorigenesis, development and metastasis and its impact on tumor prognosis.